Synthesis and pharmacology of the enantiomers of the potential atypical antipsychotic agents 5-OMe-BPAT and 5-OMe-(2,6-di-OMe)-BPAT

The optically pure enantiomers of the potential atypical antipsychotic agen ts 5-methoxy-2-[N-(2-benzamidoethyl)-N-n-propylamino]tetralin (5-OMe-BPAT, 5) and 5-methoxy-2-{N-[2-(2,6-dimethoxy)benzamidoethyl]-N-n-propylamino}tet ralin [5-OMe-(2,6-di-OMe)-BPAT, 6] were synthesized and evaluated for their in vitro binding affinities at alpha(1)-, alpha(2)-, and beta-adrenergic, muscarinic, dopamine D-1, D-2A,D- and D-3, and serotonin 5-HT1A and 5-HT2 r eceptors. In addition, their intrinsic efficacies at serotonin 5-HT1A recep tors were established in vitro. (S)- and (R)-5 had high affinities for dopa mine D2A, D3, and serotonin 5-HT1A receptors: moderate affinities for alpha (1)-adrenergic and serotonin 5-HT2 receptors, and no affinity (K-i > 1000 n M) for the other receptor subtypes. (S)- and (R)-6 had lower affinities for the dopamine D-2A and the serotonin 5-HT1A receptor, compared to (S)- and (R)-5, and hence showed some selectivity for the dopamine D3 receptor. The interactions with the receptors were stereospecific, since the serotonin 5- HT1A receptor preferred the (S)-enantiomers, while the dopamine D-2A and D- 2 receptors preferred the (R)-enantiomers of 5 and 6. The intrinsic efficac ies at the serotonin 5-HT1A receptor were established by measuring their ab ility to inhibit VIP-induced cAMP production in GH(4)ZD10 cells expressing serotonin 5-HT1A receptors. Both enantiomers of 5 behaved as full serotonin 5-HT1A receptor agonists in this assay, while both enantiomers of 6 behave d as weak partial agonists. The potential antipsychotic properties of (S)- and (R)-5 were evaluated by establishing their ability to inhibit d-ampheta mine-induced locomotor activity in rats, while their propensity to induce e xtrapyramidal side-effects (EPS) in man was evaluated by determining their ability to induce catalepsy in rats. Whereas (R)-5 was capable of blocking d-amphetamine-induced locomotor activity, indicative of dopamine D-2 recept or antagonism, (S)-5 even enhanced the effect of d-amphetamine, suggesting that this compound has dopamine D-2 receptor-stimulating properties. Since both enantiomers also were devoid of cataleptogenic activity, they are inte resting candidates for further exploring the dopamine D-2/serotonin 5-HT1A hypothesis of atypical antipsychotic drug action. (C) 1999 Elsevier Science Ltd. All rights reserved.